SnagRx vs Lemonaid Health: Compounded GLP-1 pricing and coverage compared

Quick verdict: SnagRx is the clearer option for price-sensitive users who want a named clinician network, named US 503A pharmacies, next-day shipping and a price lock across titration. Lemonaid Health lacks verified captured pricing, pharmacy, and state coverage details in the supplied evidence, so prospective users must confirm eligibility, medications, total cost and terms before enrolling.

See SnagRx pricing and plan details

SnagRx vs Lemonaid Health: how they differ at a glance

This comparison focuses on the most distinctive supported differences from the supplied material: explicit pricing and price-lock policy, compounded medication status and regulatory notes, named clinician and pharmacy partners plus shipping speed, and the completeness of published enrollment details and state coverage.

1) Pricing and price-lock policy

SnagRx lists compounded semaglutide from $69/month and compounded tirzepatide from $119/month on a 12-month plan and states the rate is “locked flat at every dose and at renewal”. The same medications are listed as $99 and $149 month-to-month. The evidence shows these are 12-month plan rates and that the advertised $69 and $119 figures require the 12-month commitment.

Lemonaid Health: current pricing and starting-price details were not published or could not be verified on the captured landing page. The supplied evidence explicitly notes that pricing, eligibility, pharmacy and state coverage may change and that users should confirm live offers.

Check Lemonaid Health eligibility and offers

2) Compounded medications and regulatory notes

SnagRx sells compounded semaglutide and tirzepatide and includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The SnagRx material encourages prospective users to speak with their provider about risks and benefits of compounded medication.

Lemonaid Health evidence states that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. No more granular captured details were provided.

3) Clinician network, named pharmacies, and shipping

SnagRx names its clinician network (OpenLoop Health) and named US 503A partner pharmacies, and states clinician review typically occurs within five hours and approved orders ship next-day via UPS or FedEx in temperature-controlled packaging. SnagRx also states a full refund if a prescription is declined and mentions a 6-month weight-loss guarantee (terms apply).

Lemonaid Health: the captured evidence does not provide named pharmacy partners, clinician review times, or shipping details. The supplied summary recommends confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.

Review SnagRx clinician and shipping info

4) State coverage and enrollment transparency

SnagRx states its OpenLoop Health clinician network covers 48 states; it does not claim nationwide coverage in the supplied evidence. SnagRx also states its intake takes about five minutes and that OpenLoop clinicians typically review within five hours and always within 24.

Lemonaid Health evidence in the capture is incomplete: captured landing-page evidence was not readable and current details were not published or could not be verified. The supplied guidance is that people should confirm eligibility, state availability and terms before enrolling.

Comparison table: SnagRx vs Lemonaid Health

What the supplied evidence supports: direct takeaways

• SnagRx is explicit on price: compounded semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan, with a stated price lock across doses and renewals.
• SnagRx names its clinician network (OpenLoop Health) and US 503A partner pharmacies and documents typical review and shipping timelines in the captured content.
• Lemonaid Health captured evidence lacked verifiable pricing, pharmacy, state coverage and renewal terms; the supplied material advises confirming live offers and eligibility.
• Both sources note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality where mentioned in the capture.

Confirm Lemonaid Health live offer and eligibility

Start SnagRx intake and view plans

Conclusion: Choose based on verified priorities

SnagRx vs Lemonaid Health: the supplied evidence supports SnagRx for users who prioritize low published annual-plan pricing, a stated price-lock at every dose, named clinician and pharmacy partners and next-day shipping. Lemonaid Health cannot be fully compared from the supplied capture because pricing, eligibility, pharmacy and state coverage were not verified; prospective users should confirm those live details before enrolling.

Choose SnagRx if…

You want compounded semaglutide from $69/month on a 12-month plan, a named clinician network (OpenLoop Health), named US 503A pharmacies, and a stated price lock across titration and renewal.

Choose Lemonaid Health if…

You need to confirm current pricing, medication options, state availability and renewal terms directly with Lemonaid Health because those details were not verified in the supplied evidence.